667 related articles for article (PubMed ID: 6400195)
1. Biodegradable polymers in controlled drug delivery.
Heller J
Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
[TBL] [Abstract][Full Text] [Related]
2. Bioerodible polymers for ocular drug delivery.
Deshpande AA; Heller J; Gurny R
Crit Rev Ther Drug Carrier Syst; 1998; 15(4):381-420. PubMed ID: 9736417
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists.
Pitt CG; Marks TA; Schindler A
NIDA Res Monogr; 1981; 28():232-53. PubMed ID: 6791007
[TBL] [Abstract][Full Text] [Related]
4. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
Kimura M; Takai M; Ishihara K
J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
[TBL] [Abstract][Full Text] [Related]
5. Poly(ortho ester) biodegradable polymer systems.
Heller J; Himmelstein KJ
Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
7. The characteristics of spontaneously forming physically cross-linked hydrogels composed of two water-soluble phospholipid polymers for oral drug delivery carrier I: hydrogel dissolution and insulin release under neutral pH condition.
Nam K; Watanabe J; Ishihara K
Eur J Pharm Sci; 2004 Nov; 23(3):261-70. PubMed ID: 15489127
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable microsphere contraceptive system.
Beck LR; Cowsar D
Acta Eur Fertil; 1980 Jun; 11(2):139-50. PubMed ID: 7211111
[TBL] [Abstract][Full Text] [Related]
9. Controlled diffusional release of dispersed solute drugs from biodegradable implants of various geometries.
Collins R; Paul Z; Reynolds DB; Short RF; Wasuwanich S
Biomed Sci Instrum; 1997; 33():137-42. PubMed ID: 9731349
[TBL] [Abstract][Full Text] [Related]
10. Extended release of a large amount of highly water-soluble diltiazem hydrochloride by utilizing counter polymer in polyethylene oxides (PEO)/polyethylene glycol (PEG) matrix tablets.
Kojima H; Yoshihara K; Sawada T; Kondo H; Sako K
Eur J Pharm Biopharm; 2008 Oct; 70(2):556-62. PubMed ID: 18606223
[TBL] [Abstract][Full Text] [Related]
11. Modeling of swelling and drug release behavior of spontaneously forming hydrogels composed of phospholipid polymers.
Nam K; Watanabe J; Ishihara K
Int J Pharm; 2004 May; 275(1-2):259-69. PubMed ID: 15081156
[TBL] [Abstract][Full Text] [Related]
12. Controlled release using a new bioerodible polyphosphazene matrix system.
Laurencin CT; Koh HJ; Neenan TX; Allcock HR; Langer R
J Biomed Mater Res; 1987 Oct; 21(10):1231-46. PubMed ID: 3693386
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
Reza MS; Quadir MA; Haider SS
J Pharm Pharm Sci; 2003; 6(2):282-91. PubMed ID: 12935440
[TBL] [Abstract][Full Text] [Related]
14. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of biologically active compounds from bioerodible polymers.
Heller J
Biomaterials; 1980 Jan; 1(1):51-7. PubMed ID: 6258660
[TBL] [Abstract][Full Text] [Related]
16. Materials and biological aspects of synthetic polymers in controlled drug release systems: problems and challenges.
Bruck SD; Mueller EP
Crit Rev Ther Drug Carrier Syst; 1988; 5(3):171-87. PubMed ID: 3060266
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive in vivo monitoring of drug release and polymer erosion from biodegradable polymers by EPR spectroscopy and NMR imaging.
Mäder K; Bacic G; Domb A; Elmalak O; Langer R; Swartz HM
J Pharm Sci; 1997 Jan; 86(1):126-34. PubMed ID: 9002472
[TBL] [Abstract][Full Text] [Related]
18. Hydrogels in controlled release formulations: network design and mathematical modeling.
Lin CC; Metters AT
Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1379-408. PubMed ID: 17081649
[TBL] [Abstract][Full Text] [Related]
19. A review of parenteral sustained-release naltrexone systems.
Olsen JL; Kincl FA
NIDA Res Monogr; 1981; 28():187-93. PubMed ID: 6791004
[TBL] [Abstract][Full Text] [Related]
20. Implantable controlled release systems.
Langer R
Pharmacol Ther; 1983; 21(1):35-51. PubMed ID: 6353438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
